Antiproliferative and Antiangiogenic Activities of Smenospongine, a Marine Sponge Sesquiterpene Aminoquinone

被引:40
作者
Kong, Dexin [1 ,2 ,3 ]
Yamori, Takao [3 ]
Kobayashi, Motomasa [4 ]
Duan, Hongquan [1 ,2 ]
机构
[1] Tianjin Med Univ, Sch Pharmaceut Sci, Tianjin 300070, Peoples R China
[2] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin 300070, Peoples R China
[3] Japanese Fdn Canc Res, Div Mol Pharmacol, Ctr Canc Chemotherapy, Koto Ku, Tokyo 1358550, Japan
[4] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan
来源
MARINE DRUGS | 2011年 / 9卷 / 02期
关键词
smenospongine; antiangiogenesis; antiproliferation; CELL LINE PANEL; ERYTHROID-DIFFERENTIATION; DRUG DISCOVERY; K562; CELLS; IN-VITRO; ANGIOGENESIS; LEUKEMIA; JFCR39; VIVO;
D O I
10.3390/md9020154
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We previously reported that smenospongine, a sesquiterpene aminoquinone isolated from the marine sponge Dactylospongia elegans, showed antiproliferative or cytotoxic activities on leukemia cells. In this study, we investigated the effect of smenospongine on solid tumors. Since angiogenesis is well known to be closely involved in growth and metastasis of solid tumors, the antiangiogenic effect of smenospongine was determined. We found that smenospongine inhibited proliferation, migration and tube formation of human umbilical vein endothelial cells (HUVEC). Moreover, the inhibitory activity of smenospongine on growth of solid tumor cells was investigated. Smenospongine inhibited the growth of 39 human solid cancer cells in vitro, with a mean Log GI(50) value of -5.55. In conclusion, smenospongine exhibits antitumor activity on solid tumors via two mechanisms, an antiangiogenic effect on endothelial cells and direct inhibition of growth of tumor cells.
引用
收藏
页码:154 / 161
页数:8
相关论文
共 13 条
  • [1] Sesquiterpene aminoquinones, from a marine sponge, induce erythroid differentiation in human chronic myelogenous leukemia, K562 cells
    Aoki, S
    Kong, D
    Matsui, K
    Rachmat, R
    Kobayashi, M
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (08) : 935 - 937
  • [2] Smenospongine, a spongean sesquiterpene aminoquinone, induces erythroid differentiation in K562 cells
    Aoki, S
    Kong, D
    Matsui, K
    Kobayashi, M
    [J]. ANTI-CANCER DRUGS, 2004, 15 (04) : 363 - 369
  • [3] Angiogenesis
    Folkman, J
    [J]. ANNUAL REVIEW OF MEDICINE, 2006, 57 : 1 - 18
  • [4] Opinion - Angiogenesis: an organizing principle for drug discovery?
    Folkman, Judah
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (04) : 273 - 286
  • [5] Cytotoxic Terpene Quinones from Marine Sponges
    Gordaliza, Marina
    [J]. MARINE DRUGS, 2010, 8 (12): : 2849 - 2870
  • [6] SMENOSPONGINE - A CYTOTOXIC AND ANTIMICROBIAL AMINOQUINONE ISOLATED FROM SMENOSPONGIA SP
    KONDRACKI, ML
    GUYOT, M
    [J]. TETRAHEDRON LETTERS, 1987, 28 (47) : 5815 - 5818
  • [7] ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system
    Kong, De-xin
    Yamori, Takao
    [J]. ACTA PHARMACOLOGICA SINICA, 2010, 31 (09) : 1189 - 1197
  • [8] Smenospongine, a sesquiterpene aminoquinone from a marine sponge, induces G1 arrest or apoptosis in different leukemia cells
    Kong, Dexin
    Aoki, Shunji
    Sowa, Yoshihiro
    Sakai, Toshiyuki
    Kobayashi, Motomasa
    [J]. MARINE DRUGS, 2008, 6 (03): : 480 - 488
  • [9] Inhibition profiles of phosphatidylinositol 3-kinase inhibitors against PI3K superfamily and human cancer cell line panel JFCR39
    Kong, Dexin
    Dan, Shingo
    Yamazaki, Kanami
    Yamori, Takao
    [J]. EUROPEAN JOURNAL OF CANCER, 2010, 46 (06) : 1111 - 1121
  • [10] Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor
    Kong, Dexin
    Okamura, Mutsumi
    Yoshimi, Hisashi
    Yamori, Takao
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (05) : 857 - 865